Amaya Lopez Bustinduy

Rhode Island Hospital

$1,319,194

Attributed

$2,638,388

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $537.9K · FY2017–22

$1M$750K$500K$250K$0

'17

'18

'19

'20

'21

'22

Funding mix

By agency

NIH$2,638,388 · 2

By mechanism

R01$2,433,001 · 1

R34$205,387 · 1

Top collaborators

Jennifer F Friedman6 shared

Most similar at Rhode Island Hospital

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Adult”

Beth Baseler · Leidos Biomedical Research, Inc.$127,607,354
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$93,592,175
Susan M Landau · University Of California Berkeley$47,252,026
Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
Evan Z Macosko · Broad Institute, Inc.$32,116,761

Research focus

AdultAge GroupAfricanAnodesAntibodiesAntigensAnemiaArea Under CurveBaseBiological MarkersBurden Of IllnessCathodesChemotherapyChildChildhoodCohortCommunitiesCross-Over TrialsCytokineDoseDrug EfficacyDrug ExposureDrug KineticsDrug Usage

Grant awards (6)

Phase II PK/PD driven dose finding trial of Praziquantel in children under four$458,712

R01 · FY2022 · HD

Phase II PK/PD driven dose finding trial of Praziquantel in children under four$473,021

R01 · FY2021 · HD

Phase II PK/PD driven dose finding trial of Praziquantel in children under four$485,722

R01 · FY2020 · HD

Phase II PK/PD driven dose finding trial of Praziquantel in children under four$477,657

R01 · FY2019 · HD

Phase II PK/PD driven dose finding trial of Praziquantel in children under four$537,889

R01 · FY2018 · HD

Praziquantel for children under four: A Phase II PK/PD driven dose finding trial$205,387

R34 · FY2017 · AI